Ireland
--:--IST
Latest
Clinical Trials in Denmark / NCT05956366
Recruiting Observational

Effectiveness of Family-based Intervention for Youn Persons With Eating Disorders

NCT05956366 · tracked via the Priya Life Science Denmark tracker
Phase
Observational
Started
2018-04-01
Last updated
2024-04-03

Condition(s) studied

Eating Disorders

Investigational drug(s) / intervention(s)

Family-based treatment

Family-based treatment: Open-end family therapy ad modum The Maudsley model

Study summary

This research project aims to characterize a naturalistic cohort of children and adolescents with eating disorders in terms of biological, psychological and psychopathological features. Further, the project will examine the effectiveness of treatment, the determinants of treatment outcome and the course of treatment response for children and adolescents with eating disorders (ED), treated in a generic specialist child and adolescent mental health service. The first choice of treatment is outpatient family-based treatment (FBT), which has documented effect for anorexia nervosa and bulimia nervosa. However, a subgroup of young persons with eating disorders does not respond sufficiently to this treatment, and evidence concerning effective treatment for children and adolescents with atypical eating disorders is still lacking. Further, treatment effectiveness for children and adolescents in a Danish naturalistic setting has never been examined.

Eligibility

Sex
ALL
Min age
7 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * begin treatment for eating disorder Exclusion Criteria: * lack of informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Child and Adolescent Mental Health Care Center Copenhagen Denmark Recruiting

More Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05956366 on ClinicalTrials.gov ↗ ← All trials in Denmark